Canada's Medicago begins human trials of plant-based COVID-19 vaccine

The Jerusalem Post

Medicago's potential vaccine uses the leaves of a plant from the tobacco family to produce the S-spike protein, one of the three spike proteins of the novel coronavirus. https://www.jpost.com/health-science/canadas-medicago-begins-human-trials-of-plant-based-covid-19-vaccine-635010